Search results for "portion"

showing 10 items of 902 documents

Perceived effectiveness, restrictiveness and compliance with containment measures against the Covid-19 pandemic: an international comparative study i…

2021

National governments took action to delay the transmission of the coronavirus (SARS-CoV-2) by implementing different containment measures. We developed an online survey that included 44 different containment measures. We aimed to assess how effective citizens perceive these measures, which measures are perceived as violation of citizens’ personal freedoms, which opinions and demographic factors have an effect on compliance with the measures, and what governments can do to most effectively improve citizens’ compliance. The survey was disseminated in 11 countries: UK, Belgium, Netherlands, Bulgaria, Czech Republic, Finland, India, Latvia, Poland, Romania, and Sweden. We acquired 9543 unique r…

MaleHealth Toxicology and Mutagenesiscoronaviruscontainment measureslcsh:MedicineEffectivenessrestrictiveness0302 clinical medicineBelgiumPandemicHuman rights030212 general & internal medicineBulgariaFinlandhealth care economics and organizationsmedia_commonCzech RepublicNetherlandsHuman rightsPublic economicsHälsovetenskaperproportionality principle3. Good healthpublic health measuresCovid-19medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)media_common.quotation_subjecteffectivenessIndiahuman rightscomplianceArticleCompliance (psychology)03 medical and health sciencesHealth SciencesmedicineHumansFinancial compensationProportionality principleRestrictivenessPandemicsSwedenPandemicRomaniaSARS-CoV-2Public healthpandemiclcsh:RPublic Health Environmental and Occupational HealthCOVID-19LatviaCoronavirusContainmentBusinessPoland030217 neurology & neurosurgery
researchProduct

Prevalence and prognostic implications of active cytomegalovirus infection in patients with acute heart failure

2010

AHF (acute heart failure) causes significant morbidity and mortality. Recent studies have postulated that the expression of inflammatory mediators, such as cytokines and chemokines, plays an important role in the development and progression of heart failure. A pro-inflammatory state has been postulated as a key factor in triggering CMV (cytomegalovirus) reactivation. Therefore we sought to determine the prevalence of active CMV infection in immunocompetent patients admitted for AHF and to quantify the association with the risk of the combined end point of death or AHF readmission. A total of 132 consecutive patients admitted for AHF were enrolled in the present study. Plasma CMV DNAaemia wa…

MaleHuman cytomegalovirusmedicine.medical_specialtyHeart diseaseCytomegalovirus030204 cardiovascular system & hematologyPatient ReadmissionGastroenterology03 medical and health sciences0302 clinical medicineInterquartile rangeBetaherpesvirinaeInternal medicineHumansMedicineRisk factorAged030304 developmental biologyAged 80 and overHeart Failure0303 health sciencesbiologybusiness.industryProportional hazards modelHazard ratiovirus diseasesGeneral MedicineLength of StayMiddle AgedPrognosismedicine.diseasebiology.organism_classification3. Good healthHeart failureAcute DiseaseCytomegalovirus InfectionsDNA ViralImmunologyMedicineCytokinesFemaleVirus ActivationInflammation MediatorsEpidemiologic MethodsbusinessClinical Science
researchProduct

Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality

2018

Background: The prognostic value of long-term potassium monitoring and dynamics in heart failure has not been characterized completely. We sought to determine the association between serum potassium values collected at follow-up with all-cause mortality in a prospective and consecutive cohort of patients discharged from a previous acute heart failure admission. Methods: Serum potassium was measured at every physician-patient encounter, including hospital admissions and ambulatory settings. The multivariable-adjusted association of serum potassium with mortality was assessed by using comprehensive state-of-the-art regression methods that can accommodate time-dependent exposure modeling. Res…

MaleHyperkalemiaPotassiumheart failure030204 cardiovascular system & hematology0302 clinical medicinecohort studiesCause of DeathRisk of mortalitylongitudinal studies030212 general & internal medicineProspective StudiesAged 80 and overpotassiumHazard ratioMiddle AgedPrognosisHypokalemiaCardiologyFemalemedicine.symptomCardiology and Cardiovascular Medicineacute heart failure; heart failure; hyperkalemia; hypokalemia; longitudinal cohort study; mortality; potassiumGlomerular Filtration RateRiskmedicine.medical_specialtyacute heart failurechemistry.chemical_elementHypokalemia03 medical and health sciencesPhysiology (medical)Internal medicinehypokalemiamedicineHumansIntensive care medicineAgedProportional Hazards ModelsHeart Failurebusiness.industryProportional hazards modellongitudinal cohort studyhyperkalemiamedicine.diseasemortalitySurvival AnalysisConfidence intervalchemistryHeart failurePotassiumPotentiometryHyperkalemiabusiness
researchProduct

Association of Osteoarthritis with Increased Risk of Cardiovascular Diseases in the Elderly: Findings from the Progetto Veneto Anziano Study Cohort

2015

Objective The possible relevance of osteoarthritis (OA) as a cardiovascular disease (CVD) risk factor is still debated. The aim of this study was to investigate the association between OA and the onset of CVD in older individuals. Methods Among a sample of 3,099 elderly subjects, 2,158 were identified as having no CVD at baseline and were followed up for a mean ± SD 4.4 ± 1.2 years. OA was defined using a standardized algorithm that investigated disease history, medical documentation (including radiographic reports), symptoms, and physical examination of the joints. Incident CVD was defined as the onset of coronary artery disease, heart failure, stroke/transient ischemic attack, peripheral …

MaleIMPACTImmunologyUNITED-STATESPROGRESSIONCoronary Artery DiseaseKNEE OSTEOARTHRITISNOCohort StudiesPeripheral Arterial DiseaseRheumatologyImmunology; Immunology and Allergy; RheumatologyRisk FactorsOsteoarthritisEPIDEMIOLOGYHumansImmunology and AllergyObesityAgedDyslipidemiasProportional Hazards ModelsAged 80 and overHeart FailureDISABILITYMORTALITYIncidencePREVALENCEHospitalizationLipoproteins LDLStrokeATHEROSCLEROSISItalyCardiovascular DiseasesIschemic Attack TransientHypertensionFemaleARTHRITISFollow-Up Studies
researchProduct

Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are creat…

2009

Contains fulltext : 80963.pdf (Publisher’s version ) (Open Access) BACKGROUND: The extent to which mortality differs following individual acquired immunodeficiency syndrome (AIDS)-defining events (ADEs) has not been assessed among patients initiating combination antiretroviral therapy. METHODS: We analyzed data from 31,620 patients with no prior ADEs who started combination antiretroviral therapy. Cox proportional hazards models were used to estimate mortality hazard ratios for each ADE that occurred in >50 patients, after stratification by cohort and adjustment for sex, HIV transmission group, number of antiretroviral drugs initiated, regimen, age, date of starting combination antiretrovir…

MaleInfectious diseases and international health [NCEBP 13]Lymphoma030312 virologyEsophageal candidiasisCohort Studies0302 clinical medicineInterquartile range030212 general & internal medicineAIDS-RelatedLymphoma AIDS-Related0303 health sciencesMortality rateProgressive multifocal leukoencephalopathyHazard ratioPrognosis3. Good healthPathogenesis and modulation of inflammation [N4i 1]Infectious DiseasesCombinationDrug Therapy CombinationFemaleInfection and autoimmunity [NCMLS 1]HumanMicrobiology (medical)Adultmedicine.medical_specialtyPrognosiAnti-HIV Agentsantiretroviral therapyInfectious DiseaseArticleAIDS-Related Opportunistic Infection03 medical and health sciencesAcquired immunodeficiency syndrome (AIDS)Drug TherapyInternal medicinemedicineHumansAIDS-defining eventProportional Hazards ModelsAIDS-Related Opportunistic Infections/diagnosis/ mortality; Acquired Immunodeficiency Syndrome/complications/diagnosis/drug; therapy/ mortality; Adult; Anti-HIV Agents/ therapeutic use; Cohort Studies; Drug Therapy; Combination; Female; Humans; Lymphoma; AIDS-Related/diagnosis/mortality; Male; Prognosis; Proportional Hazards ModelsAcquired Immunodeficiency SyndromeAIDS-Related Opportunistic Infectionsbusiness.industryProportional hazards modelPoverty-related infectious diseases [N4i 3]Anti-HIV Agentmedicine.diseasemortalityConfidence intervalImmunologyProportional Hazards ModelCohort Studiebusiness
researchProduct

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.

2018

In this independent, multicenter, retrospective study, we investigated the short-term persistence to treatment with first-line self-injectable or oral disease-modifying treatments (DMTs) in patients with relapsing–remitting multiple sclerosis. Data of patients regularly attending 21 Italian MS Centres who started a self-injectable or an oral DMT in 2015 were collected to: (1) estimate the proportion of patients discontinuing the treatment; (3) explore reasons for discontinuation; (3) identify baseline predictors of treatment discontinuation over a follow-up period of 12 months. We analyzed data of 1832 consecutive patients (1289 women, 543 men); 374 (20.4%) of them discontinued the prescrib…

MaleInjectionTime FactorsPatient Dropoutdisease-modifying therapies; multiple sclerosis; outcome measurement; persistence to treatment; quality of lifeAdministration OralSelf AdministrationSex FactorKaplan-Meier EstimateRelapsing-Remittingmultiple sclerosisImmunologic Factor0302 clinical medicineQuality of lifeRetrospective StudieRisk FactorsMedicine030212 general & internal medicineDisease-modifying therapiedisease-modifying therapiesDisease-modifying therapies Multiple sclerosis Outcome measurement Persistence to treatment Quality of life Administration Oral Adult; Female Follow-Up Studies Humans Immunologic Factors Injections Kaplan-Meier EstimateMale Multiple Sclerosis Relapsing-Remitting Patient Dropouts Prognosis Proportional Hazards Models Retrospective Studies Risk Factors Self Administration Sex Factors Time FactorsHazard ratioPrognosisNeurologyTolerabilityAdministrationSettore MED/26 - NeurologiaFemaleoutcome measurementHumanOralAdultmedicine.medical_specialtyPatient DropoutsTime FactorPrognosiFollow-Up StudieInjections03 medical and health sciencesRoute of administrationMultiple Sclerosis Relapsing-RemittingSex FactorsInternal medicineHumansImmunologic FactorsMultiple sclerosiAdverse effectProportional Hazards ModelsRetrospective Studiesbusiness.industryProportional hazards modelRisk FactorRetrospective cohort studyDiscontinuationDisease-modifying therapies; Multiple sclerosis; Outcome measurement; Persistence to treatment; Quality of life; Administration Oral; Adult; Female; Follow-Up Studies; Humans; Immunologic Factors; Injections; Kaplan-Meier Estimate; Male; Multiple Sclerosis Relapsing-Remitting; Patient Dropouts; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Self Administration; Sex Factors; Time Factorsquality of lifeProportional Hazards Modelpersistence to treatmentNeurology (clinical)business030217 neurology & neurosurgeryFollow-Up StudiesJournal of neurology
researchProduct

Therapeutic implications of low lymphocyte count in non-ST segment elevation acute coronary syndromes

2009

Abstract Background Low lymphocyte count (LLC), a surrogate for inflammation, has emerged as a potential risk factor for cardiovascular outcomes, especially new ischemic events. To identify patients with non-ST segment elevation acute coronary syndromes (NSTEACS) who benefit from an invasive revascularization strategy remains a challenge. We sought to determine if patients with high-risk NSTEACS who exhibited LLC have a greater reduction in long-term post-discharge myocardial infarction (MI) when managed under a revascularization invasive strategy (RIS) as compared with conservative strategy (CS). Methods Nine hundred seventy two consecutive patients with high-risk NSTEACS were treated unde…

MaleInvasive strategymedicine.medical_specialtyLymphocytemedicine.medical_treatmentMyocardial InfarctionRevascularizationElectrocardiographyRisk FactorsLymphopeniaInternal medicineMyocardial RevascularizationInternal MedicineHumansMedicineST segmentLymphocyte CountMyocardial infarctionAcute Coronary SyndromeLow lymphocyte countAgedProportional Hazards ModelsRetrospective Studiesbusiness.industryProportional hazards modelPrognosismedicine.diseaseTreatment Outcomemedicine.anatomical_structureQuartileCardiologyFemalebusinessEuropean Journal of Internal Medicine
researchProduct

High-sensitivity troponin assay improves prediction of cardiovascular risk in patients with cerebral ischaemia

2013

Background and purpose Clinical scores are recommended for predicting cardiovascular risk in patients with cerebral ischaemia to inform secondary prevention. Blood biomarkers may improve prediction beyond clinical scores. Methods Within the observational Find-AF trial (ISRCTN46104198), 197 patients >18 years of age with cerebral ischaemia and without atrial fibrillation had blood sampled at baseline. The predictive value of five biomarkers for a combined vascular endpoint (acute coronary syndrome, stroke, cardiovascular death) and all-cause mortality was determined, alone and in addition to the Essen Stroke Risk Score (ESRS), Stroke Prognostic Instrument 2 (SPI-2) and National Institutes of…

MaleKaplan-Meier Estimate030204 cardiovascular system & hematologyBrain IschemiaCohort Studies0302 clinical medicineNatriuretic Peptide BrainMedicine1506Prospective StudiesProspective cohort studyStrokeTroponin TAtrial fibrillationMiddle AgedPrognosisTroponin3. Good healthStrokePsychiatry and Mental healthCardiovascular DiseasesIschemic Attack TransientPredictive value of testsCardiologyFemaleFatty Acid Binding Protein 3Atrial Natriuretic Factormedicine.medical_specialtyAcute coronary syndromeGrowth Differentiation Factor 15Endpoint DeterminationCardiologyFatty Acid-Binding ProteinsRisk Assessment03 medical and health sciencesTroponin TPredictive Value of TestsInternal medicineHumansSurvival analysisAgedbusiness.industryProportional hazards modelmedicine.diseaseSurvival AnalysisPeptide FragmentsSurgeryCerebrovascular DiseaseSurgeryNeurology (clinical)businessBiomarkers030217 neurology & neurosurgeryFollow-Up StudiesJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Longitudinal associations of high‐volume and vigorous‐intensity exercise with hip fracture risk in men

2022

Maintenance of vigorous exercise habits from young to old age is considered protective against hip fractures, but data on fracture risk in lifelong vigorous exercisers are lacking. This longitudinal cohort study examined the hazard of hip fractures in 1844 male former athletes and 1216 population controls and in relation to exercise volume and intensity in later years. Incident hip fractures after age 50 years were identified from hospital discharge register from 1972 to 2015. Exercise and covariate information was obtained from questionnaires administered in 1985, 1995, 2001, and 2008. Analyses were conducted using extended proportional hazards regression model for time-dependent exposures…

MaleLONG-TERMEndocrinology Diabetes and MetabolismosteoporoosiPARTICIPATIONEXERCISEpitkittäistutkimusOSTEOPOROSISDISEASEAGINGTIME PHYSICAL-ACTIVITYRisk FactorsHumansQUALITYlongitudinal studiesOrthopedics and Sports MedicineluunmurtumatAgedProportional Hazards ModelsREGISTERexerciseHip FractureskuntoliikuntaagingLONGITUDINAL STUDIESMiddle AgedosteoporosislonkkaFRACTURE PREVENTIONLIFESIZEikääntyminenBALANCE3121 General medicine internal medicine and other clinical medicinefracture preventionmiehetBONE-MINERAL DENSITYikääntyneet
researchProduct

Low-dose vitamin D supplementation and incident frailty in older people: An eight year longitudinal study.

2018

Hypovitaminosis D is associated with frailty, but if vitamin D supplementation may prevent the onset of frailty is poorly known. Therefore, we aimed to investigate whether vitamin D supplementation is associated with a lower risk of frailty. In this longitudinal study, 4,421 individuals at high risk or having knee osteoarthritis free from frailty at baseline (mean age: 61.3, females = 58.0%) were followed for 8 years. Details regarding vitamin D supplementation were captured by asking whether the participant took vitamin D during the previous year, at least once per month. Frailty was defined using the Study of Osteoporotic Fracture (SOF) index as the presence of at least two of the followi…

MaleLongitudinal studyAging*Osteoarthritis initiativeBiochemistry0302 clinical medicineEndocrinologyOutcome Assessment Health CareMedicine030212 general & internal medicineOlder adult*FrailtyVitamin D*Older adultsFrailtyIncidence (epidemiology)Osteoarthritis initiativeConfoundingHazard ratioVitaminsMiddle AgedOlder adultsFemale*Vitamin Dmedicine.medical_specialty030209 endocrinology & metabolismFrailty; Older adults; Osteoarthritis initiative; Vitamin DLower riskArticle03 medical and health sciencesInternal medicineWeight LossGeneticsVitamin D and neurologyHumansMobility LimitationPropensity ScoreMolecular BiologyAgedProportional Hazards Modelsbusiness.industryCell BiologyVitamin D DeficiencyConfidence intervalUnited StatesPropensity score matchingDietary SupplementsPhysical therapybusinessOsteoporotic FracturesFollow-Up StudiesExperimental gerontology
researchProduct